Pediatrics
News from the FDA/CDC
FDA OKs empagliflozin for children with type 2 diabetes
This approval represents only the second oral treatment option for children and adolescents with type 2 diabetes after metformin.
News
Warts difficult to eradicate in immunocompromised children
Warts completely resolved with treatment in only 24% of children undergoing active cancer treatment.
News
SPF is only the start when recommending sunscreens
In a recent study, 43% of dermatologists who responded to a survey reported that they never, rarely, or only sometimes took a patient’s skin type...
News
JAK-inhibitor safety in adolescents with AD: Long-term analyses reported
For abrocitinib, "we're starting to get good numbers of [adolescents] who've had about 2 years of exposure," Dr. Lawrence Eichenfield said.
News
Facial, hand, and foot dermatitis: Lebrikizumab and dupilumab show efficacy in new studies
"Lebrikizumab was efficacious in clearing and improving facial and hand dermatitis, burdensome and difficult-to-treat areas, in most patients," Dr...
Conference Coverage
Can this tool forecast peanut allergies?
The predictive scorecard captures 14 images from one infant of mixed race, two White infants, two Black infants, and two Hispanic infants.
News
Bundled strategy increased preteen lipid screening
An intervention included in-office testing, provider education, and EMR updates.
News
Contact allergens lurk in diabetes devices
Some reports suggest that at any given time, skin complications may affect as many as one quarter to one half of patients who use diabetes devices...
News
Beware the hidden allergens in nutritional supplements
A detailed history of supplement use is important, as it may reveal possible allergens as the cause of previously unidentified reactions.
Conference Coverage
Step count–heart rate link confirmed in children
The new findings provide a new means for pediatricians to measure physical fitness.